title: Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.
abstract: Prostate MRI is currently the best diagnostic imaging method for detecting PCa. Magnetic resonance imaging (MRI)/ultrasonography (US) fusion allows the sensitivity and specificity of MRI to be combined with the real-time capabilities of transrectal ultrasonography (TRUS). Multiple approaches and techniques exist for MRI/US fusion and include direct 'in bore' MRI biopsies, cognitive fusion, and MRI/US fusion via software-based image coregistration platforms.
authors.affiliation: Urologic Oncology Branch, National Cancer Institute, USA.
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Logan
authors.forename: Soroush
authors.initials: S
authors.lastname: Rais-Bahrami
authors.forename: Baris
authors.initials: B
authors.lastname: Turkbey
authors.forename: Andrew
authors.initials: A
authors.lastname: Gomella
authors.forename: Hayet
authors.initials: H
authors.lastname: Amalou
authors.forename: Peter L
authors.initials: PL
authors.lastname: Choyke
authors.forename: Bradford J
authors.initials: BJ
authors.lastname: Wood
authors.forename: Peter A
authors.initials: PA
authors.lastname: Pinto
mesh_terms: D006801:Humans; D061705:Image-Guided Biopsy / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011467:Prostate / Q000000981:diagnostic imaging* / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*; D012984:Software; D014463:Ultrasonography / Q000379:methods*
keywords: MRI/US fusion; MRI/US fusion platforms; prostate MRI; targeted biopsy